MedPath

Effects of integrated neuromuscular inhibition technique on upper trapezius trigger points in patients with non specific neck pai

Not Applicable
Recruiting
Conditions
on specific neck pain.
Panniculitis affecting regions of neck and back, cervical region
M54.02
Registration Number
IRCT20220104053617N1
Lead Sponsor
niversity of Lahore
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
48
Inclusion Criteria

Subjects suffering from non-specific neck pain, defined as non-articular or non-systemic as per the referring physician.
Subjects will be required to have neck pain of less than 3 months duration as well as active TrPs inthe upper trapezius muscle, defined as a tender nodule in a taut band that referred pain beyondthe area of contact

Exclusion Criteria

If patiant with neck symptoms will be related to a motor vehicle collision or significant trauma, they will not be included in our study
If patiants will be presenting with signs of serious pathology (e.g. malignancy, infection, inflammatorydisorder, or fracture), then he/she will not be included in the trial
Patients with signs of cervical spinal cord compromise (e.g. diffuse sensory abnormality, diffuse weakness, hyperreflexia, or the presence of clonus), two or more signs of nerve rootinvolvement (e.g. dermatomal sensation changes, myotomal weakness, or diminished/absenttendon jerk reflexes)
A history of neck surgery during the previous 12 months, and a history of cervical degenerativejoint disease as per radiographs, endocrine disorders, and autoimmune conditions (e.g. rheumatoid arthritis, fibromyalgia, etc.)
If pateints had received trigger point injections in the upper trapezius muscle within the past 6 months, they will not be included in our study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: Pain will be assessed at Baseline and after every week for 4 weeks. Method of measurement: Visual Analog Scale will be utilized for the assessment of pain.;Functional disability. Timepoint: Functional Disability will be assessed at Baseline and after every week for 4 weeks. Method of measurement: Neck Disability Index will be utilized for this purpose.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath